Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ayako Fukata"'
Autor:
Takanobu Yamazaki, Ayako Fukata
Publikováno v:
Naunyn-Schmiedeberg's Archives of Pharmacology. 386:1095-1102
The prevalence of overactive bladder (OAB) and Alzheimer's disease (AD) increases with age, and much attention has been paid to the risk of cognitive impairment which may be induced by antimuscarinics used for OAB in patients with AD. Imidafenacin, a
Publikováno v:
European journal of pharmacology. 791
Imidafenacin, an antimuscarinic agent for treating overactive bladder, has an antidiuretic effect, but the detailed mechanisms of action remain unclear. The cholinergic and vasopressin systems are known to interact, for example, in the suppression of
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 336(2)
The binding of orally administered imidafenacin, used to treat overactive bladders, to muscarinic receptors in rat tissue was characterized based on pharmacokinetics. The binding in six tissues including bladder tissue was measured using [ N -methyl-
Autor:
Kohzo Nagata, Yasuo Koike, Aya Matsushita, Mitsunori Iwase, Hirotaka Kimata, Akiko Noda, Mitsuhiro Yokota, Keiko Hayashi, Koji Obata, Katsunori Hashimoto, Ayako Fukata
Publikováno v:
Journal of cardiac failure. 14(3)
Background Oxidative stress is implicated in cardiac remodeling and failure. We tested whether xanthine oxidase (XO) inhibition could decrease myocardial oxidative stress and attenuate left ventricular (LV) remodeling and dysfunction in the TO-2 hams
Autor:
Takao Nishizawa, Yurie Kasai, Mitsuhiro Yokota, Yasuo Koike, Yuriko Kato, Kohzo Nagata, Masaaki Miyachi, Hiroki Yazawa, Mayuko Kato, Koji Tsuboi, Ayako Fukata
Publikováno v:
Journal of Cardiac Failure. 13:S53